DAVID M REESE Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID M REESE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID M REESE. DAVID M REESE is EVP, Research and Development in AMGEN INC ($AMGN).
Latest Insider Trading Transactions of DAVID M REESE
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 04 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Option Exercise | A | 239.64 | 34,782 | 8,335,158 | 34,782 | |
| May 04 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 239.64 | 745 | 178,532 | 44,472 | 45.2 K to 44.5 K (-1.65 %) |
| May 04 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 239.64 | 1,109 | 265,761 | 45,217 | 46.3 K to 45.2 K (-2.39 %) |
| May 04 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 4,006 | 0 | 46,326 | 42.3 K to 46.3 K (+9.47 %) |
| Apr 28 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 255.52 | 174 | 44,460 | 42,320 | 42.5 K to 42.3 K (-0.41 %) |
| Mar 22 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 244.42 | 1,401 | 342,432 | 42,494 | 43.9 K to 42.5 K (-3.19 %) |
| Mar 04 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 2,803 | 0 | 43,715 | 40.9 K to 43.7 K (+6.85 %) |
| Feb 16 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Option Exercise | M | 54.69 | 2,300 | 125,787 | 0 | |
| Feb 16 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 237.21 | 1,147 | 272,080 | 40,912 | 42.1 K to 40.9 K (-2.73 %) |
| Feb 16 2021 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Buy | M | 54.69 | 2,300 | 125,787 | 42,059 | 39.8 K to 42.1 K (+5.78 %) |
| May 07 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Option Exercise | A | 236.36 | 29,050 | 6,866,258 | 29,050 | |
| May 07 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 3,469 | 0 | 41,408 | 37.9 K to 41.4 K (+9.14 %) |
| May 07 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Option Exercise | A | 236.36 | 29,050 | 6,866,258 | 29,050 | |
| May 07 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 3,469 | 0 | 41,408 | 37.9 K to 41.4 K (+9.14 %) |
| May 05 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 230.98 | 185 | 42,731 | 37,939 | 38.1 K to 37.9 K (-0.49 %) |
| May 05 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 239.22 | 1,046 | 250,224 | 38,124 | 39.2 K to 38.1 K (-2.67 %) |
| Apr 29 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 236.28 | 168 | 39,695 | 39,170 | 39.3 K to 39.2 K (-0.43 %) |
| Mar 24 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 198.76 | 1,855 | 368,700 | 39,338 | 41.2 K to 39.3 K (-4.50 %) |
| Mar 10 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Option Exercise | M | 58.43 | 1,480 | 86,476 | 0 | |
| Mar 10 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 210.65 | 780 | 164,307 | 40,985 | 41.8 K to 41 K (-1.87 %) |
| Mar 10 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Sell | M | 58.43 | 1,480 | 86,476 | 41,765 | 43.2 K to 41.8 K (-3.42 %) |
| Mar 05 2020 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 3,711 | 0 | 40,285 | 36.6 K to 40.3 K (+10.15 %) |
| May 07 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Option Exercise | A | 177.31 | 39,382 | 6,982,822 | 39,382 | |
| May 07 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 4,511 | 0 | 36,075 | 31.6 K to 36.1 K (+14.29 %) |
| May 07 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 176.50 | 174 | 30,711 | 31,564 | 31.7 K to 31.6 K (-0.55 %) |
| May 03 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 179.32 | 851 | 152,604 | 31,738 | 32.6 K to 31.7 K (-2.61 %) |
| May 03 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 179.32 | 163 | 29,230 | 32,859 | 33 K to 32.9 K (-0.49 %) |
| Mar 25 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 191.89 | 1,769 | 339,453 | 32,752 | 34.5 K to 32.8 K (-5.12 %) |
| Mar 08 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 3,676 | 0 | 34,324 | 30.6 K to 34.3 K (+11.99 %) |
| Feb 01 2019 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Payment of Exercise | F | 192.11 | 115 | 22,093 | 30,648 | 30.8 K to 30.6 K (-0.37 %) |
| Nov 06 2018 | AMGN | AMGEN INC | REESE DAVID M | EVP, Research and D ... | Grant | A | 0.00 | 12,830 | 0 | 30,618 | 17.8 K to 30.6 K (+72.13 %) |
Page: 1